甲状腺FNA细胞学:COVID-19疫情与疫苗接种的影响——巴西系列研究
结果显示疫苗后非诊断性病例较疫情前增加76.2%,恶性病例从2.3%升至5.1%,ROSE评估减少且与 adequacy 率下降相关,提示患者选择改善但标本充分性下降。
要点
- 疫苗接种后恶性病例占比升至5.1%,较疫情前增加121.2%。
- 非诊断性病例在疫苗后增加76.2%,与ROSE评估减少相关。
- 疫情两阶段中TBSRTC IV、V、VI类时间校正后增加,良性结节减少。
核心结论
- 疫苗接种前后持续较低的良性率和较高的恶性率提示FNA患者选择更优。
- 标本充分性率下降与ROSE评估数量减少相关。
研究设计与样本
- 回顾性评估2019年1月至2022年5月超声引导下甲状腺FNA及ROSE评估,按TBSRTC分类分析三个时期。
- 共纳入5815例患者的7531个结节,分疫情前(第1期)、传播至扩张期(第2期)和疫苗接种后(第3期)。
主要发现
- FNA病例总数在整个疫情期间增加,但封锁期间下降。
- 非诊断性病例在第2期较疫情前增加18.1%,疫苗后增加76.2%。
- 恶性病例从2.3%升至第2期4.2%和第3期5.1%,分别增加83.1%和121.2%。
- 时间校正后数据显示第2、3期TBSRTC IV、V、VI类增加,良性结节减少。
- ROSE评估在疫情前为787例,第2期减少29.4%,第3期减少22.8%;疫苗后ROSE与I类比值显著降低。
临床怎么用
- 疫情期间及疫苗后应关注甲状腺FNA标本充分性下降,ROSE减少可能影响 adequacy。
- 恶性率升高提示患者选择更优,但需结合TBSRTC分类变化综合判读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The coronavirus disease 2019 pandemic prompted changes in medical practice, with a reduction in cytopathology volumes and a relative increase in the malignancy rate during lockdown and the initial postlockdown period. To date, no study has evaluated the impact of these changes on the volume of rapid on-site evaluation (ROSE) or on the frequency of cases according to The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) categories after vaccination. METHODS: Ultrasound-guided thyroid fine-needle aspiration (FNA) and ROSE assessments performed from January 2019 to May 2022 were evaluated retrospectively according to TBSRTC categories for three periods: prepandemic (period 1), from transmission to expansion (period 2), and after vaccination (period 3). RESULTS: There were 7531 nodules from 5815 patients. FNA cases increased throughout the pandemic despite a drop during lockdown. The frequency of TBSRTC categories changed. Nondiagnostic cases had an increase of 18.1% in period 2 and 76.2% after vaccination compared with prepandemic levels. Malignant cases increased from 2.3% to 4.2% in period 2 and to 5.1% in period 3, representing increases of 83.1% and 121.2%, respectively, compared with period 1. Data corrected by time showed increases in categories IV, V, and VI and a decrease in benign nodules during the two pandemic periods. ROSE was performed in 787 cases during the prepandemic period, and there were decreases of 29.4% and 22.8% in periods 2 and 3, respectively. The ROSE-to-category I ratio was reduced significantly after vaccination. CONCLUSIONS: Increased volume with sustained lower benign rates and higher malignant rates before and after vaccination indicate better selection of patients for FNA. A worse adequacy rate was correlated with a decrease in the number of ROSE assessments.
引用
- de Andrade Natal R, Bedin AR, Giongo AA, et al. Thyroid FNA cytology: Impact of the COVID-19 pandemic and vaccination in a Brazilian series. Cancer Cytopathol. 2023. PMID: 37747447. doi:10.1002/cncy.22763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。